Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes

Author： Tsubouchi Y.   Sano H.   Yamada R.   Hashiramoto A.   Kohno M.   Kusaka Y.   Kondo M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.395, Iss.3, 2000-05, pp. : 255-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Meloxicam: A Cyclo-Oxygenase-2 Preferential Nonsteroidal Anti-Inflammatory Drug

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 36, Iss. 2, 1999-02 ,pp. : 115-126

Adis International

Access to resources Recommend Favorite

Auranofin inhibits interleukin-1 -induced transcript of cyclooxygenase-2 on cultured human synoviocytes

By Yamada R.   Sano H.   Hla T.   Hashiramoto A.   Fukui W.   Miyazaki S.   Kohno M.   Tsubouchi Y.   Kusaka Y.   Kondo M.  

European Journal of Pharmacology, Vol. 385, Iss. 1, 1999-11 ,pp. : 71-79

Elsevier

Access to resources Recommend Favorite

Cyclooxygenase-2 Inhibition and Gastric Cancer

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2281-2288

Bentham Science Publishers

Access to resources Recommend Favorite

Articular Diffusion of Meloxicam After a Single Oral Dose: Relationship to Cyclo-Oxygenase Inhibition in Synovial Cells

By Guillaume C.  

Clinical Pharmacokinetics, Vol. 39, Iss. 5, 2000-11 ,pp. : 369-382

Adis International

Access to resources Recommend Favorite

Meloxicam in rheumatoid arthritis

By Ahmed Mansoor   Khanna Dinesh   Furst Daniel E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 739-751

Informa Healthcare

Access to resources Recommend Favorite